interesting that Herve Gisserot , whom csl installed to run vifor, was previously running China for GSK:
Gisserot hails from GSK, where he’s held a clutch of senior vice president roles over the past 13 years. Gisserot currently serves as SVP and head of pharmaceuticals and vaccines, greater China and intercontinental, at the British Big Pharma, according to his LinkedIn profile.Since 2013, he’s been a staple in GSK’s China business. That year, Gisserot was tapped to right the ship as GSK’s SVP and general manager in China and Hong Kong, replacing GSK’s previous China GM Mark Reilly
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$257.38 |
Change
8.990(3.62%) |
Mkt cap ! $124.6B | |||
| Open | High | Low | Value | Volume |
| $252.00 | $258.31 | $251.10 | $370.9M | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $257.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $257.38 | 3331 | 1 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |